NS5 protein inhibitors (Collaboration Pharmaceuticals/Universidade Federal de Goias/University of California San Diego/University of Sao Paulo/University of North Carolina/Rutgers New Jersey Medical School)
N/A
Report date: 2025/03/20 10:05:53
NME
Base Information
Drug NameNS5 protein inhibitors (Collaboration Pharmaceuticals/Universidade Federal de Goias/University of California San Diego/University of Sao Paulo/University of North Carolina/Rutgers New Jersey Medical School)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversidade Federal De Goias
China Registration ClassN/A
Develop Information
Active CompaniesNew Jersey Medical SchoolUniversity Of North Carolina, GreensboroCollaborations Pharmaceuticals Inc +[6]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A